CN114847486A - 一种含灵芝提取物多种维生素片的制作方法 - Google Patents
一种含灵芝提取物多种维生素片的制作方法 Download PDFInfo
- Publication number
- CN114847486A CN114847486A CN202110144994.4A CN202110144994A CN114847486A CN 114847486 A CN114847486 A CN 114847486A CN 202110144994 A CN202110144994 A CN 202110144994A CN 114847486 A CN114847486 A CN 114847486A
- Authority
- CN
- China
- Prior art keywords
- vitamin
- percent
- ganoderma lucidum
- lucidum extract
- plant
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 240000008397 Ganoderma lucidum Species 0.000 title claims abstract description 38
- 235000001637 Ganoderma lucidum Nutrition 0.000 title claims abstract description 38
- 239000000284 extract Substances 0.000 title claims abstract description 34
- 238000000034 method Methods 0.000 title claims abstract description 8
- 238000003756 stirring Methods 0.000 claims abstract description 21
- 239000011248 coating agent Substances 0.000 claims abstract description 17
- 238000000576 coating method Methods 0.000 claims abstract description 17
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims description 32
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 claims description 32
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 claims description 30
- 229930003270 Vitamin B Natural products 0.000 claims description 28
- 235000019156 vitamin B Nutrition 0.000 claims description 28
- 239000011720 vitamin B Substances 0.000 claims description 28
- 239000000843 powder Substances 0.000 claims description 18
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 claims description 16
- 229930003268 Vitamin C Natural products 0.000 claims description 16
- 235000019359 magnesium stearate Nutrition 0.000 claims description 16
- 235000019154 vitamin C Nutrition 0.000 claims description 16
- 239000011718 vitamin C Substances 0.000 claims description 16
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims description 15
- 229930006000 Sucrose Natural products 0.000 claims description 15
- FAPWYRCQGJNNSJ-UBKPKTQASA-L calcium D-pantothenic acid Chemical compound [Ca+2].OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O.OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O FAPWYRCQGJNNSJ-UBKPKTQASA-L 0.000 claims description 15
- 229960002079 calcium pantothenate Drugs 0.000 claims description 15
- 229960003512 nicotinic acid Drugs 0.000 claims description 15
- 239000011664 nicotinic acid Substances 0.000 claims description 15
- 235000001968 nicotinic acid Nutrition 0.000 claims description 15
- 229960004793 sucrose Drugs 0.000 claims description 15
- 229920002261 Corn starch Polymers 0.000 claims description 14
- UEDUENGHJMELGK-HYDKPPNVSA-N Stevioside Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O UEDUENGHJMELGK-HYDKPPNVSA-N 0.000 claims description 14
- 239000008120 corn starch Substances 0.000 claims description 14
- 229960003495 thiamine Drugs 0.000 claims description 14
- 229920001353 Dextrin Polymers 0.000 claims description 13
- 239000004375 Dextrin Substances 0.000 claims description 13
- 235000019425 dextrin Nutrition 0.000 claims description 13
- 229940013618 stevioside Drugs 0.000 claims description 13
- OHHNJQXIOPOJSC-UHFFFAOYSA-N stevioside Natural products CC1(CCCC2(C)C3(C)CCC4(CC3(CCC12C)CC4=C)OC5OC(CO)C(O)C(O)C5OC6OC(CO)C(O)C(O)C6O)C(=O)OC7OC(CO)C(O)C(O)C7O OHHNJQXIOPOJSC-UHFFFAOYSA-N 0.000 claims description 13
- 235000019202 steviosides Nutrition 0.000 claims description 13
- 239000005720 sucrose Substances 0.000 claims description 13
- 241000222336 Ganoderma Species 0.000 claims description 12
- 241000196324 Embryophyta Species 0.000 claims description 11
- 229930003451 Vitamin B1 Natural products 0.000 claims description 11
- 235000010374 vitamin B1 Nutrition 0.000 claims description 11
- 239000011691 vitamin B1 Substances 0.000 claims description 11
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 claims description 10
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 claims description 7
- 229930003471 Vitamin B2 Natural products 0.000 claims description 7
- 229960002477 riboflavin Drugs 0.000 claims description 7
- 235000019164 vitamin B2 Nutrition 0.000 claims description 7
- 239000011716 vitamin B2 Substances 0.000 claims description 7
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 claims description 6
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 claims description 5
- 239000011726 vitamin B6 Substances 0.000 claims description 5
- 235000019158 vitamin B6 Nutrition 0.000 claims description 5
- 229940011671 vitamin b6 Drugs 0.000 claims description 5
- 238000004519 manufacturing process Methods 0.000 claims description 3
- 239000000463 material Substances 0.000 claims description 3
- 239000012467 final product Substances 0.000 claims description 2
- 239000002075 main ingredient Substances 0.000 claims description 2
- 238000010298 pulverizing process Methods 0.000 claims description 2
- 239000002994 raw material Substances 0.000 claims description 2
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 claims 2
- 230000000694 effects Effects 0.000 abstract description 11
- 239000003814 drug Substances 0.000 abstract description 10
- 235000013305 food Nutrition 0.000 abstract description 9
- 229940088594 vitamin Drugs 0.000 abstract description 9
- 229930003231 vitamin Natural products 0.000 abstract description 9
- 235000013343 vitamin Nutrition 0.000 abstract description 9
- 239000011782 vitamin Substances 0.000 abstract description 9
- 230000004060 metabolic process Effects 0.000 abstract description 6
- 238000005728 strengthening Methods 0.000 abstract description 6
- 150000003722 vitamin derivatives Chemical class 0.000 abstract description 6
- 235000013402 health food Nutrition 0.000 abstract description 4
- 230000009286 beneficial effect Effects 0.000 abstract description 3
- 238000002360 preparation method Methods 0.000 abstract description 3
- 239000000126 substance Substances 0.000 abstract description 3
- 230000036039 immunity Effects 0.000 abstract description 2
- 230000008621 organismal health Effects 0.000 abstract description 2
- 208000000412 Avitaminosis Diseases 0.000 abstract 1
- 206010021135 Hypovitaminosis Diseases 0.000 abstract 1
- 230000037213 diet Effects 0.000 abstract 1
- 235000005911 diet Nutrition 0.000 abstract 1
- 238000004806 packaging method and process Methods 0.000 abstract 1
- 239000013589 supplement Substances 0.000 abstract 1
- 208000030401 vitamin deficiency disease Diseases 0.000 abstract 1
- KYMBYSLLVAOCFI-UHFFFAOYSA-N thiamine Chemical compound CC1=C(CCO)SCN1CC1=CN=C(C)N=C1N KYMBYSLLVAOCFI-UHFFFAOYSA-N 0.000 description 13
- 239000000047 product Substances 0.000 description 12
- 239000003826 tablet Substances 0.000 description 12
- 238000001727 in vivo Methods 0.000 description 6
- 238000005303 weighing Methods 0.000 description 6
- 206010029240 Neuritis Diseases 0.000 description 5
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 description 4
- 210000004369 blood Anatomy 0.000 description 4
- 239000008280 blood Substances 0.000 description 4
- 210000002216 heart Anatomy 0.000 description 4
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 3
- 102000004190 Enzymes Human genes 0.000 description 3
- 108090000790 Enzymes Proteins 0.000 description 3
- JZRWCGZRTZMZEH-UHFFFAOYSA-N Thiamine Natural products CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N JZRWCGZRTZMZEH-UHFFFAOYSA-N 0.000 description 3
- 206010047601 Vitamin B1 deficiency Diseases 0.000 description 3
- -1 Vitamin B2 vitamin Chemical class 0.000 description 3
- 150000001413 amino acids Chemical class 0.000 description 3
- 208000002894 beriberi Diseases 0.000 description 3
- 201000001119 neuropathy Diseases 0.000 description 3
- 239000000546 pharmaceutical excipient Substances 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 235000019157 thiamine Nutrition 0.000 description 3
- 239000011721 thiamine Substances 0.000 description 3
- 206010011224 Cough Diseases 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 208000005232 Glossitis Diseases 0.000 description 2
- 241000282414 Homo sapiens Species 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- 208000002720 Malnutrition Diseases 0.000 description 2
- 206010029400 Nicotinic acid deficiency Diseases 0.000 description 2
- 208000002141 Pellagra Diseases 0.000 description 2
- 241000209504 Poaceae Species 0.000 description 2
- 206010039793 Seborrhoeic dermatitis Diseases 0.000 description 2
- 206010047700 Vomiting Diseases 0.000 description 2
- 229930013930 alkaloid Natural products 0.000 description 2
- 206010003549 asthenia Diseases 0.000 description 2
- 208000006673 asthma Diseases 0.000 description 2
- 210000003169 central nervous system Anatomy 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 201000006549 dyspepsia Diseases 0.000 description 2
- 150000004676 glycans Chemical class 0.000 description 2
- 210000000265 leukocyte Anatomy 0.000 description 2
- 201000002364 leukopenia Diseases 0.000 description 2
- 231100001022 leukopenia Toxicity 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 230000001071 malnutrition Effects 0.000 description 2
- 235000000824 malnutrition Nutrition 0.000 description 2
- 210000004877 mucosa Anatomy 0.000 description 2
- 229960003966 nicotinamide Drugs 0.000 description 2
- 235000005152 nicotinamide Nutrition 0.000 description 2
- 239000011570 nicotinamide Substances 0.000 description 2
- 208000015380 nutritional deficiency disease Diseases 0.000 description 2
- 229920001282 polysaccharide Polymers 0.000 description 2
- 239000005017 polysaccharide Substances 0.000 description 2
- 208000008742 seborrheic dermatitis Diseases 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- OILXMJHPFNGGTO-UHFFFAOYSA-N (22E)-(24xi)-24-methylcholesta-5,22-dien-3beta-ol Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)C=CC(C)C(C)C)C1(C)CC2 OILXMJHPFNGGTO-UHFFFAOYSA-N 0.000 description 1
- RQOCXCFLRBRBCS-UHFFFAOYSA-N (22E)-cholesta-5,7,22-trien-3beta-ol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)C=CCC(C)C)CCC33)C)C3=CC=C21 RQOCXCFLRBRBCS-UHFFFAOYSA-N 0.000 description 1
- GOLORTLGFDVFDW-UHFFFAOYSA-N 3-(1h-benzimidazol-2-yl)-7-(diethylamino)chromen-2-one Chemical compound C1=CC=C2NC(C3=CC4=CC=C(C=C4OC3=O)N(CC)CC)=NC2=C1 GOLORTLGFDVFDW-UHFFFAOYSA-N 0.000 description 1
- OQMZNAMGEHIHNN-UHFFFAOYSA-N 7-Dehydrostigmasterol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)C=CC(CC)C(C)C)CCC33)C)C3=CC=C21 OQMZNAMGEHIHNN-UHFFFAOYSA-N 0.000 description 1
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 241000208838 Asteraceae Species 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 241000871189 Chenopodiaceae Species 0.000 description 1
- 240000005250 Chrysanthemum indicum Species 0.000 description 1
- RGJOEKWQDUBAIZ-IBOSZNHHSA-N CoASH Chemical compound O[C@@H]1[C@H](OP(O)(O)=O)[C@@H](COP(O)(=O)OP(O)(=O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCS)O[C@H]1N1C2=NC=NC(N)=C2N=C1 RGJOEKWQDUBAIZ-IBOSZNHHSA-N 0.000 description 1
- 208000002881 Colic Diseases 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- 206010010741 Conjunctivitis Diseases 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- DNVPQKQSNYMLRS-NXVQYWJNSA-N Ergosterol Natural products CC(C)[C@@H](C)C=C[C@H](C)[C@H]1CC[C@H]2C3=CC=C4C[C@@H](O)CC[C@]4(C)[C@@H]3CC[C@]12C DNVPQKQSNYMLRS-NXVQYWJNSA-N 0.000 description 1
- 241000221017 Euphorbiaceae Species 0.000 description 1
- 241001489091 Ganoderma sinense Species 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- 208000031226 Hyperlipidaemia Diseases 0.000 description 1
- 206010020741 Hyperpyrexia Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 206010020850 Hyperthyroidism Diseases 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 240000003183 Manihot esculenta Species 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 206010028813 Nausea Diseases 0.000 description 1
- 208000001738 Nervous System Trauma Diseases 0.000 description 1
- 208000007443 Neurasthenia Diseases 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 208000000474 Poliomyelitis Diseases 0.000 description 1
- 206010036105 Polyneuropathy Diseases 0.000 description 1
- 241000222341 Polyporaceae Species 0.000 description 1
- 206010037549 Purpura Diseases 0.000 description 1
- 241001672981 Purpura Species 0.000 description 1
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- 206010044302 Tracheitis Diseases 0.000 description 1
- 241000209140 Triticum Species 0.000 description 1
- 208000007642 Vitamin B Deficiency Diseases 0.000 description 1
- 208000003056 Vitamin B6 deficiency Diseases 0.000 description 1
- 206010047623 Vitamin C deficiency Diseases 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000007244 Zea mays Nutrition 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 238000009098 adjuvant therapy Methods 0.000 description 1
- 201000003465 angular cheilitis Diseases 0.000 description 1
- 208000022531 anorexia Diseases 0.000 description 1
- 230000003266 anti-allergic effect Effects 0.000 description 1
- 230000009876 antimalignant effect Effects 0.000 description 1
- 235000015191 beet juice Nutrition 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 235000001465 calcium Nutrition 0.000 description 1
- 229960005069 calcium Drugs 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 230000023852 carbohydrate metabolic process Effects 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 208000007287 cheilitis Diseases 0.000 description 1
- 239000003638 chemical reducing agent Substances 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 238000009535 clinical urine test Methods 0.000 description 1
- RGJOEKWQDUBAIZ-UHFFFAOYSA-N coenzime A Natural products OC1C(OP(O)(O)=O)C(COP(O)(=O)OP(O)(=O)OCC(C)(C)C(O)C(=O)NCCC(=O)NCCS)OC1N1C2=NC=NC(N)=C2N=C1 RGJOEKWQDUBAIZ-UHFFFAOYSA-N 0.000 description 1
- 239000005515 coenzyme Substances 0.000 description 1
- 239000005516 coenzyme A Substances 0.000 description 1
- 229940093530 coenzyme a Drugs 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 206010061428 decreased appetite Diseases 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- KDTSHFARGAKYJN-UHFFFAOYSA-N dephosphocoenzyme A Natural products OC1C(O)C(COP(O)(=O)OP(O)(=O)OCC(C)(C)C(O)C(=O)NCCC(=O)NCCS)OC1N1C2=NC=NC(N)=C2N=C1 KDTSHFARGAKYJN-UHFFFAOYSA-N 0.000 description 1
- 210000002249 digestive system Anatomy 0.000 description 1
- 230000000916 dilatatory effect Effects 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- DNVPQKQSNYMLRS-SOWFXMKYSA-N ergosterol Chemical compound C1[C@@H](O)CC[C@]2(C)[C@H](CC[C@]3([C@H]([C@H](C)/C=C/[C@@H](C)C(C)C)CC[C@H]33)C)C3=CC=C21 DNVPQKQSNYMLRS-SOWFXMKYSA-N 0.000 description 1
- DQYBDCGIPTYXML-UHFFFAOYSA-N ethoxyethane;hydrate Chemical compound O.CCOCC DQYBDCGIPTYXML-UHFFFAOYSA-N 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- 208000030533 eye disease Diseases 0.000 description 1
- 201000005577 familial hyperlipidemia Diseases 0.000 description 1
- 239000007941 film coated tablet Substances 0.000 description 1
- 239000007888 film coating Substances 0.000 description 1
- 238000009501 film coating Methods 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- JTLXCMOFVBXEKD-FOWTUZBSSA-N fursultiamine Chemical compound C1CCOC1CSSC(\CCO)=C(/C)N(C=O)CC1=CN=C(C)N=C1N JTLXCMOFVBXEKD-FOWTUZBSSA-N 0.000 description 1
- 229950006836 fursultiamine Drugs 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000005986 heart dysfunction Effects 0.000 description 1
- 208000006454 hepatitis Diseases 0.000 description 1
- 231100000283 hepatitis Toxicity 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 208000030603 inherited susceptibility to asthma Diseases 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 206010023332 keratitis Diseases 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 230000005923 long-lasting effect Effects 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 229940063002 magnesium palmitate Drugs 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- ABSWXCXMXIZDSN-UHFFFAOYSA-L magnesium;hexadecanoate Chemical compound [Mg+2].CCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCC([O-])=O ABSWXCXMXIZDSN-UHFFFAOYSA-L 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 230000008693 nausea Effects 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 210000000653 nervous system Anatomy 0.000 description 1
- 208000028412 nervous system injury Diseases 0.000 description 1
- 208000004296 neuralgia Diseases 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 239000013588 oral product Substances 0.000 description 1
- 229940023486 oral product Drugs 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 231100000915 pathological change Toxicity 0.000 description 1
- 230000036285 pathological change Effects 0.000 description 1
- 210000000578 peripheral nerve Anatomy 0.000 description 1
- 239000000810 peripheral vasodilating agent Substances 0.000 description 1
- 229960002116 peripheral vasodilator Drugs 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 208000019629 polyneuritis Diseases 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 230000002980 postoperative effect Effects 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 239000003223 protective agent Substances 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 238000006479 redox reaction Methods 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 201000003068 rheumatic fever Diseases 0.000 description 1
- 208000010233 scurvy Diseases 0.000 description 1
- 229910052711 selenium Inorganic materials 0.000 description 1
- 239000011669 selenium Substances 0.000 description 1
- 208000017520 skin disease Diseases 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 150000003431 steroids Chemical class 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 208000003265 stomatitis Diseases 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 201000000596 systemic lupus erythematosus Diseases 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 230000002936 tranquilizing effect Effects 0.000 description 1
- 150000003648 triterpenes Chemical class 0.000 description 1
- 230000004382 visual function Effects 0.000 description 1
- 235000019195 vitamin supplement Nutrition 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/15—Vitamins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L31/00—Edible extracts or preparations of fungi; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Mycology (AREA)
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Microbiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
本发明涉及一种含灵芝提取物植物多种维生素片的制作方法。其采用投料、粉碎、搅拌、制压片、包衣包装工序制作而成。另外,本发明还提供了一种上述多种维生素片的制作方法。本发明的灵芝提取物与植物多种维生素的功效集于一体,使如今的大多数人群来说,食品或者保健食品已经成为人们日常生活中,不可或缺的一部分,食品或者保健食品可以能有效地补充日常饮食中维生素不足的现象,维生素是维持机体正常代谢和机体健康必不可少的重要物质,人们在平时口服维生素片的同时,摄入了灵芝提取物对机体有益的扶正固本、滋补强身有效功效成分。本发明的灵芝提取物植物多种维生素片,有祖国传统中药灵芝提取物,维持机体正常代谢,提高机体免疫力功能,一举两得。
Description
技术领域
本发明涉及食品加工领域和保健食品加工领域。
背景技术
灵芝为多孔菌类灵芝属植物赤芝或紫芝的子实体,灵芝又称灵芝草、菌灵芝、木灵芝。灵芝含麦角甾醇、氨基酸、蛋白质、糖类、生物碱、树脂、香豆精及多种酶类。灵芝甘、平。入心、肺、脾、肝、肾经。具有养心安神,补气益血,止咳平喘的功效。经试验能增强中枢神经***功能,强心,改善冠脉血循环,降低血脂,调节血压,保护肝脏,促进血中白细胞增加,增强机体免疫功能,并有抗过敏作用,又能止咳、祛痰。临床用于:冠心病、高血压、高血脂
心率紊乱、白细胞减少症、病后体虚、神经衰弱、慢性气管炎、支气管哮喘、肝炎、消化不良、风湿性关节炎等。《神农本草经》《本草纲目》等古代中医文献都有关于灵芝的论述,灵芝的发源地在中国,中国先民在六千多年前就已经利用灵芝了,灵芝是祖国医药瑰宝。
维生素B1为维生素类药,具有维持正常糖代谢及神经、消化***功能,用于防治因维生素B1缺乏所致的脚气病、多发性神经炎、周围神经炎、中枢神经***损伤、食欲不振、消化不良、营养不良及心功能障碍等,亦用于高热和甲状腺功能亢进患者。丙硫硫胺又称新维生素B1,为维生素B1的衍生物,其用途与维生素B1相同,因具有脂溶性,故吸收较快,且与组织细胞有较强的亲和力,***慢,不易被硫胺酶分解,作用较持久。用于脚气病和维生素B1而致的营养障碍等。呋喃硫胺又称长效维生素B1,为维生素B1的衍生物中疗效较好毒性较低的长效化合物,在体内能迅速转变成活性型硫胺,不为体内硫胺酶所破坏,对组织的亲和力强,脏器内浓度高,血中浓度增加快,存留时间长,疗效显著。用于各种神经炎、神经疼、小儿麻痹后遗症、小儿验尿症等,对药物引起的神经***副作用亦有一定疗效。维生素B2位维生素类药,参与体内商务氧化作用,并能维持眼睛正常视觉功能。用于缺乏维生素B2的各种粘膜、皮肤及眼部疾类如角膜炎、结膜炎口角炎、舌炎、脂溢性皮炎、阴囊炎等维生素B6位维生素类药,参与氨基酸及脂肪的代谢。用于防治因长期服用异肼而引起的周围神经炎、妊娠呕吐、放射病,使用抗恶性肿瘤药所致的恶心、呕吐,维生素B6缺乏而至的中枢神经***周围神经的病变,脂溢性皮炎等,与烟酰胺合用。治疗糙皮病,此外可刺激白细胞的生成,治疗白细胞减少症。烟酸为维生素类药,在体内变成烟酰胺,烟酰胺是辅酶的组成部分,参与体内多种代谢过程,并有扩张小血管的作用。用于防治糙皮病、口炎、舌炎,也用于周围血管扩张药及治疗高脂血症等。泛酸钙为维生素B1属之一,是辅酶A的组成部分,参与蛋白质、脂肪、糖代谢。用于维生素B缺乏症以及周围神经炎、手术后肠绞痛与维生素C合用治疗播散性红斑性狼疮。维生素C具有还原剂的作用,参与体内氧化还原反应中发挥传递氢的作用及细胞间质的生成。用于防治坏血病、各种急慢性传染病及紫癜等的辅助治疗。蔗糖由禾本科植物蔗糖或藜科植物甜菜汁中得到的一种糖,摘要用作矫味剂,亦用作散剂的赋刑剂。糊精为禾本科植物小麦未成熟的颖果,含多量淀粉和维生素B等。玉米淀粉为禾本科植物玉蜀黍的颖果或大戟科植物木薯块根中制得的多糖类颗粒,有吸着力,可作为混悬剂及粘膜保护剂,又可用作片剂、散剂的赋形剂。甜菊糖由菊科菊属植物的干燥头状花序甘菊汁中得到的一种糖,常用作用剂、散剂或浸膏的稀释剂及赋形剂。硬脂酸镁为硬脂酸镁与棕榈酸镁的混合物,由硬脂酸镁与硫酸镁进行复分解制得。为白色轻松无砂性的细粉,微有特臭,与皮肤接触,有清腻感。不溶于水、乙醇或***,主要作片剂的润滑剂。包衣粉为保护剂、赋形剂要粘合剂,为片剂最外一层薄膜衣片,为可溶性薄膜衣。然而,迄今为止,现有技术还没有任何关于含灵芝提取物植物维生素片的报道。
发明内容
为了弥补现有技术中存在的上述不足,本发明的一个目的在于提供一种含灵芝提取物植物多种维生素片。本发明的另一个目的在于提供一种用于生产含灵芝提取物植物多种维生素片的制作方法。
说明书:
为了实现上述发明目的,根据本发明的一方面,本发明提供一种含灵芝提取物的植物多种维生素中,其主要组成配料成分包括:灵芝提取物、维生素B1、丙硫硫胺、呋喃硫胺、维生素B2、维生素B6、烟酸、泛酸钙、维生素C、蔗糖、糊精、玉米淀粉、甜菊糖、硬脂酸镁、包衣粉。所述成分的重量百分含量为:灵芝提取物28.5-33.5%、维生素B1 21.0-24.0%、丙硫硫胺18.0-20.0%、呋喃硫胺15.0-17.5%、维生素B2 7.5-9.5%、维生素B6 35.0-37.0%、烟酸10.0-12.5%、泛酸钙6.5-11.5%、维生素C 40.0-43.5%、蔗糖32.0-3.5.0%、糊精0.7-0.9%、玉米淀粉0.5-0.8%、甜菊糖0.2-0.6%、硬脂酸镁0.1-0.2%、包衣粉0.6-0.9%。
根据本发明的另外一方面,本发明还提供了一种用于生产含灵芝提取物植物多种维生素片制作方法,该方法包括以下步骤:
1)将溶器中,加入辅料重量百分比为32.0-35.0%蔗糖,粉碎。加入0.7-0.9%糊精、0.5-0.8%玉米淀粉、0.2-.0.6%甜菊糖,搅拌均匀;
2)加入21.0-24.0%维生素B1、18.0-20.0%丙硫硫胺、15.0-17.5%呋喃硫胺、7.5-9.5%维生素B2 、35.0-37.0%维生素B6、10.0-12.5%烟酸、6.5-11.5%泛酸钙、40.0-43.5%维生素C、搅拌均匀;
3)加入28.5-33.5%灵芝提取物,搅拌均匀;
4)加入0.1-0.2%硬脂酸镁,搅拌均匀;
5)制片、压片、包衣时,加入0.6-0.9%包衣粉,即得成品。
本发明提供的含灵芝提取物植物多种维生素片兼含中药灵芝成分,灵芝和维生素各自的功效集于一体,使如今的大多数人群来说,食品或者保健食品已成为人们日常生活中,不可或缺的一部分,食品或者保健食品是维持机体正常代谢和身体健康必不可少的重要物质,人们在口服维生素片的同时,摄入灵芝提取物对人体有益的扶正固本、滋补强身功效成分此外,本发明通过合理地配比各原料,在将多种维生素片中含量保持在可发挥良好功效的水平同时,提供了一种含灵芝提取物植物多种维生素片,且无不良反应。
主要用途:在服用时,更加方便快捷,既可当补充维生素口服,又可以当保健食品服用,帮助人们提高免疫功效,一举两得,更显健康,更显如意。
具体实施方式:
下面结合具体实施方式对于本发明进行进一步的详细描述,本领域的技术人员应当明白,以下实施例仅是用于解释而不是限定本发明,国家本发明权利要求中限定的实质和范围所作的等同变化,仍属于本发明所涵盖的范围。
如上所述,灵芝是灵芝发育后其释放出来的种子,含有效成分可分为十大类,包括灵芝粗多糖、灵芝多肽、三萜类、氨基酸、蛋白质、甾类、甘露醇、豆香精苷、生物碱、有机酸,以及微量元素硒、磷、铁、钙、镁、锌等。研究表明,灵芝提取物扶正固本、滋补强身的功效,得到了全人类的认可和肯定,灵芝提取物有益的功效,且效果显著优于中药灵芝饮片。
另外,本发明所提供的植物多种维生素片,还含有维生素B1、丙硫硫胺、呋喃硫胺、维生素B2、维生素B6、烟酸、泛酸钙、维生素C。
另外,本发明还提供了一种生产灵芝提取物植物维生素片的制作方法。
作为本发明的方法的一种优选实施方式。所述原料的重量百分比还可以为:灵芝提取物28.5-33.5%、维生素B1 21.0-24.0%、丙硫硫胺18.0-20.0%、呋喃硫胺15.0-17.5%、维生素B2 7.5-9.5%、维生素B6 10.0-12.5%、烟酸10.0-12.5%、泛酸钙6.5-11.5%、维生素C40.0-43.5%、蔗糖32.0-3.5.0%、糊精0.7-0.9%、玉米淀粉0.5-0.8%、甜菊糖0.2-0.6%、硬脂酸镁0.1-0.2%。优选地,还可在物料中加入0.6-0.9%的暴富
实施例说明:
下面将参照具体的实施对本发明的上述和其他目的特征进行更进一步的说明。
实施例1:
称取蔗糖17.0Kg,放入溶器中粉碎,加入已经称取的糊精2.0 Kg、玉米淀粉1.5Kg、甜菊糖0.5 Kg、搅拌均匀。在加入已经称取的维生素B1 11.5 Kg、丙硫硫胺9.5 Kg、呋喃硫胺11.0 Kg、维生素B2 6.5 Kg、维生素B6 16.5 Kg、烟酸7.0 Kg、泛酸钙5.5 Kg、维生素C18.5 Kg、搅拌均匀。再加入已经称取的灵芝提取物12.5 Kg,搅拌均匀。在加入就称取的硬脂酸镁0.5 Kg,搅拌均匀。制品、压片、包衣时,在加入已经称取的包衣粉0.5 Kg,即得成品。
实施例2:
称取蔗糖18.0Kg,放入溶器中粉碎,加入已经称取的糊精2.5 Kg、玉米淀粉1.0Kg、甜菊糖0.5 Kg、搅拌均匀。在加入已经称取的维生素B1 12.5 Kg、丙硫硫胺8.0 Kg、呋喃硫胺10.5Kg、维生素B2 5.5Kg、维生素B6 15 Kg、烟酸8.0 Kg、泛酸钙4.5 Kg、维生素C19.0Kg、搅拌均匀。再加入已经称取的灵芝提取物13.5 Kg,搅拌均匀。在加入就称取的硬脂酸镁0.4 Kg,搅拌均匀。制品、压片、包衣时,在加入已经称取的包衣粉0.3 Kg,即得成品。
实施例1:
称取蔗糖18.5Kg,放入溶器中粉碎,加入已经称取的糊精3.0 Kg、玉米淀粉1.2Kg、甜菊糖0.8 Kg、搅拌均匀。在加入已经称取的维生素B1 12.5 Kg、丙硫硫胺9.5 Kg、呋喃硫胺11.0 Kg、维生素B2 6.5 Kg、维生素B6 15.5 Kg、烟酸7.5 Kg、泛酸钙5.5 Kg、维生素C18.0 Kg、搅拌均匀。再加入已经称取的灵芝提取物11.0 Kg,搅拌均匀。在加入就称取的硬脂酸镁0.3 Kg,搅拌均匀。制品、压片、包衣时,在加入已经称取的包衣粉0.3Kg,即得成品。
实施例4:
称取蔗糖15.5Kg,放入溶器中粉碎,加入已经称取的糊精4.5Kg、玉米淀粉1.7 Kg、甜菊糖0.6 Kg、搅拌均匀。在加入已经称取的维生素B1 13.0 Kg、丙硫硫胺8.0 Kg、呋喃硫胺9.5Kg、维生素B2 7.5 Kg、维生素B6 14.0 Kg、烟酸6.0 Kg、泛酸钙4.5 Kg、维生素C17.0Kg、搅拌均匀。再加入已经称取的灵芝提取物12.5 Kg,搅拌均匀。在加入就称取的硬脂酸镁0.3 Kg,搅拌均匀。制品、压片、包衣时,在加入已经称取的包衣粉0.2 Kg,即得成品。
实施例5:
称取蔗糖21.0Kg,放入溶器中粉碎,加入已经称取的糊精3.8Kg、玉米淀粉2.1Kg、甜菊糖0.7 Kg、搅拌均匀。在加入已经称取的维生素B1 12.5 Kg、丙硫硫胺7.5 Kg、呋喃硫胺8.0 Kg、维生素B2 6.0 Kg、维生素B6 13.5 Kg、烟酸8.0 Kg、泛酸钙6.0 Kg、维生素C16.0Kg、搅拌均匀。再加入已经称取的灵芝提取物13.0 Kg,搅拌均匀。在加入就称取的硬脂酸镁0.2 Kg,搅拌均匀。制品、压片、包衣时,在加入已经称取的包衣粉0.1 Kg,即得成品。
实施例6:
称取蔗糖21.5Kg,放入溶器中粉碎,加入已经称取的糊精3.0 Kg、玉米淀粉1.4Kg、甜菊糖0.3 Kg、搅拌均匀。在加入已经称取的维生素B1 15.0 Kg、丙硫硫胺8.5 Kg、呋喃硫胺6.5Kg、维生素B2 5.5 Kg、维生素B6 15.0 Kg、烟酸7.0 Kg、泛酸钙5.5 Kg、维生素C18.0 Kg、搅拌均匀。再加入已经称取的灵芝提取物11.0 Kg,搅拌均匀。在加入就称取的硬脂酸镁0.4 Kg,搅拌均匀。制品、压片、包衣时,在加入已经称取的包衣粉0.2Kg,即得成品。
虽然说明书中对本发明的实施方式进行了说明,但这些实施方式只是作为提示,不应限定本发明的保护范围。在不脱离本发明宗旨的范围内进行各种省略、置换和变更应包含在本发明的保护范围内。
Claims (5)
1.一种含灵芝提取物的植物多种维生素片,其主要组成配料成分包括:灵芝提取物、维生素B1、丙硫硫胺、呋喃硫胺、维生素B2、维生素B6、烟酸、泛酸钙、维生素C、蔗糖、玉米淀粉、甜菊糖、硬脂酸镁、包衣粉。
2.如权利要求1所述的灵芝提取物植物多种维生素片,其特征在于,还含有适量的包衣粉。
3.一种用于生产如权利要求1所述的含灵芝提取物的植物多种维生素片制作方法,其特征在于,该方法包括以下步骤:
1)将溶器中,加入辅料重量百分比为32.0-35.0%蔗糖,粉碎,加入0.7-0.9%糊精、0.5-0.8%玉米淀粉、0.2-.0.6%甜菊糖,搅拌均匀;
2)加入21.0-24.0%维生素B1、18.0-20.0%丙硫硫胺、15.0-17.5%呋喃硫胺、7.5-9.5%维生素B2、35.0-37.0%维生素B6、10.0-12.5%烟酸、6.5-11.5%泛酸钙、40.0-43.5%维生素C、搅拌均匀;
3)加入28.5-33.5%灵芝提取物,搅拌均匀;
4)加入0.1-0.2%硬脂酸镁,搅拌均匀;
5)制片、压片、包衣时,加入0.6-0.9%包衣粉,即得成品。
4.如权利3所述的方法,在其特征在于,所述原料和辅料的百分配比为:灵芝提取物28.5-33.5%、维生素B1 21.0-24.0%、丙硫硫胺18.0-20.0%、呋喃硫胺15.0-17.5%、维生素B27.5-9.5%、维生素B6 10.0-12.5%、烟酸10.0-12.5%、泛酸钙6.5-11.5%、维生素C 40.0-43.5%、蔗糖32.0-35.0%、糊精0.7-0.9%、玉米淀粉0.5-0.8%、甜菊糖0.2-0.6%、硬脂酸镁0.1-0.2%。
5.如权利要求3所述的方法,其特征在于,还可以在步骤5)中向物料中加入0.6-0.9%的包衣粉。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110144994.4A CN114847486A (zh) | 2021-02-05 | 2021-02-05 | 一种含灵芝提取物多种维生素片的制作方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110144994.4A CN114847486A (zh) | 2021-02-05 | 2021-02-05 | 一种含灵芝提取物多种维生素片的制作方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN114847486A true CN114847486A (zh) | 2022-08-05 |
Family
ID=82623499
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202110144994.4A Pending CN114847486A (zh) | 2021-02-05 | 2021-02-05 | 一种含灵芝提取物多种维生素片的制作方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN114847486A (zh) |
-
2021
- 2021-02-05 CN CN202110144994.4A patent/CN114847486A/zh active Pending
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101940620B (zh) | 一种治疗糖尿病的药物组合物及其应用 | |
CN111035649B (zh) | 一种nmn+glp复配营养补充剂及其制备方法和应用 | |
CN101011561A (zh) | 黄连温胆汤现代中药口服制剂及其生产方法 | |
CN102697035A (zh) | 虫草褔寿丹 | |
CN107455625A (zh) | 一种具有抗疲劳减肥功能的植物营养素饮料及其制备工艺 | |
US7879374B2 (en) | Composition including superoxide dismutase and prickly-pear cactus for minimizing and preventing hangovers | |
WO2023005911A1 (zh) | 一种辅助治疗糖尿病的核苷酸组合物及其制备方法和应用 | |
CN109123351A (zh) | 一种具有高血糖人群代餐调节功能的特医食品及制备方法 | |
CN101664180B (zh) | 一种具有保健功效的营养复合剂及其制备方法 | |
CN100556429C (zh) | 一种含有葡萄提取物的药物组合物及其制备方法、用途 | |
CN110960624A (zh) | 一种抗疲劳的组合物及其制备方法 | |
CN117018125B (zh) | 一种用于抗疲劳的药物组合物 | |
CN107006856A (zh) | 一种增强耐力、提高抗缺氧耐受力营养剂及其制备方法 | |
CN104857154A (zh) | 一种治疗“三高”症的中药组合物及其制备方法 | |
CN101933950A (zh) | 槐耳菌质水提物的用途 | |
CN102631466A (zh) | 一种调节血脂的保健品及制备方法 | |
CN114847486A (zh) | 一种含灵芝提取物多种维生素片的制作方法 | |
CN108835471A (zh) | 一种添加黄芪的混合饮品及其制备方法 | |
CN101491605A (zh) | 一种具有降血糖功能的组合物及其制备方法 | |
CN101491668B (zh) | 一种具有降血糖功能的组合物及其制备方法 | |
CN107115295A (zh) | 一种含有冬虫夏草的液体组合物及其制备方法 | |
CN108904596B (zh) | 一种具有改善记忆力功效的组合物 | |
CN110652006A (zh) | 一种缓解体力疲劳的组合物及其制备方法 | |
CN102657333B (zh) | 降压护心复合营养剂及其制备方法 | |
CN101491584A (zh) | 一种具有降血糖功能的组合物及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
WD01 | Invention patent application deemed withdrawn after publication | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20220805 |